Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene encodes a pseudogene related to the U6 small nuclear RNA, which itself is an essential component of the major spliceosome involved in pre-mRNA splicing in eukaryotic cells[1][2]. Pseudogenes, like RNU6-1122P, are stretches of DNA that resemble known genes (here, U6 snRNA gene) but contain mutations or structural changes that prevent them from encoding functional gene products[3]. The functional, non-pseudogene U6 snRNA forms the catalytic core of the spliceosome, participates in pre-mRNA splicing via ribonucleoprotein complexes, and is highly conserved[1][2]. However, pseudogenes such as RNU6-1122P are thought to be evolutionary remnants without biological function and are not engaged in canonical RNA processing or splicing activities. *U6 small nuclear RNA (snRNA)* is essential for the catalytic steps of pre-mRNA splicing, coordinating magnesium ions in the active site of the spliceosome and facilitating the transesterification reactions required for intron removal[1][2][4]. Its pseudogenes, including RNU6-1122P, are commonly found in vertebrates and are thought to arise via genomic duplication and mutation events[3]. These pseudogenes bear sequence similarity to their functional counterparts but lack the capability for transcription and/or function[3][2]. - There are no known drugs, diagnostic markers, or therapeutic implications associated with RNU6-1122P.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1122, pseudogene (RNU6-1122P).